The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 17, 2024
Filed:
Oct. 07, 2019
Applicant:
Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, DE;
Inventors:
Dieter Wiedenmayer, Biberach an der Riss, DE;
Andreas Gollner, Vienna, AT;
Iain Lingard, Monza, IT;
Holger Wagner, Mettenberg, DE;
Assignee:
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); C07D 471/08 (2006.01); C07D 487/04 (2006.01); C07D 487/08 (2006.01); C07D 491/048 (2006.01); C07D 491/107 (2006.01); C07D 498/08 (2006.01); A61K 45/06 (2006.01); A61P 27/02 (2006.01); C07D 403/14 (2006.01); C07D 471/04 (2006.01); C07D 487/10 (2006.01); C07D 491/08 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); C07D 471/08 (2013.01); C07D 487/04 (2013.01); C07D 487/08 (2013.01); C07D 491/048 (2013.01); C07D 491/107 (2013.01); C07D 498/08 (2013.01); A61K 45/06 (2013.01);
Abstract
Disclosed are phenyltetrazole derivatives of formula (I), wherein A, R, R, X, R', R″, and n are as defined herein, and pharmaceutically acceptable salts thereof. Also disclosed are methods of using the phenyltetrazole derivatives for the treatment of diseases which can be influenced by inhibition of plasma kallikrein.